Deal Reached to Keep Health Insurance Subsidies
Our Maternity Care System Is Broken "Here's How We Can Fix It"
Eczema Drug Shows Promising Phase 2 Results for Treatment of Eosinophilic Esophagitis
UK Patients With Head and Neck Cancer Will Soon Have Access to Nivolumab
What We're Reading: Backing Bipartisan Efforts; California's State of Emergency; HSAs
Quality Talks 2017: Speakers Address Evidence, Ethics, and Value(s) in Healthcare
Gestational Diabetes Raises Heart Attack, Stroke Risk, NIH Study Finds
Study: Linoleic Acid Is Beneficial for Prevention of Type 2 Diabetes
St. Jude Study Questions Efficacy of the Flu Vaccine in Children With Leukemia
AMA Seeks to Make Health Data Work Better for Doctors, Patients
Patients With Early Small Cell Lung Cancer Respond Favorably to Opdivo, Yervoy Combo
Physician Extenders Reduce Wait Times for Dermatology Appointments, Study Finds
Public Health Initiatives Can Improve Outcomes for Out-of-Hospital Cardiac Arrest
Diagnosing and Treating Neutropenia: Q&A With Dr Daniel J. DeAngelo
What We're Reading: Anthem Reduces Premium Hikes; Second Gene Therapy; California Wildfires
Trump Ends ACA Insurer Payments
Findings Point Toward Customized Diabetes Prevention
Study: Body Fat Composition May Predict Poor Treatment Outcomes in Patients With Multiple Myeloma
Stand Up To Cancer Awards $5.5 Million for Epigenetic Immunotherapy Trials
5 Things About the Importance of Addressing Social Determinants of Health
AJMC® in the Press, October 13, 2017
This Week in Managed Care: October 13, 2017
Young Adults With ADHD Frequently Skip Medication During College Transition
Study: Improvements Needed in Post-Acute Care Interventions for AECOPD
ACOs Look to Take on More Risk, but Are Still Learning How to Be Successful
Higher Physical Activity Lowers Risk of Mortality and Cardiovascular Disease
Scott Gottlieb Announces Progress on Patient Engagement Efforts at the FDA
2017's Best and Worst Cities for People With Disabilities
Trump Signs Order to Allow Health Insurance Sales Across State Lines
Second Interim Analysis Suggests Carfilzomib Improves Survival in Multiple Myeloma